| Title : Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study - Kim_2015_Ann.Rheum.Dis_74_1968 |
| Author(s) : Kim SC , Schneeweiss S , Glynn RJ , Doherty M , Goldfine AB , Solomon DH |
| Ref : Ann Rheum Dis , 74 :1968 , 2015 |
| Abstract : Kim_2015_Ann.Rheum.Dis_74_1968 |
| ESTHER : Kim_2015_Ann.Rheum.Dis_74_1968 |
| PubMedSearch : Kim_2015_Ann.Rheum.Dis_74_1968 |
| PubMedID: 24919467 |
Kim SC, Schneeweiss S, Glynn RJ, Doherty M, Goldfine AB, Solomon DH (2015)
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study
Ann Rheum Dis
74 :1968
Kim SC, Schneeweiss S, Glynn RJ, Doherty M, Goldfine AB, Solomon DH (2015)
Ann Rheum Dis
74 :1968